List of Excipients in API betaxolol hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing betaxolol hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | BETOPTIC S | betaxolol hydrochloride | 0078-0729 | BENZALKONIUM CHLORIDE | |
| Novartis Pharmaceuticals Corporation | BETOPTIC S | betaxolol hydrochloride | 0078-0729 | EDETATE DISODIUM | |
| Novartis Pharmaceuticals Corporation | BETOPTIC S | betaxolol hydrochloride | 0078-0729 | HYDROCHLORIC ACID | |
| Novartis Pharmaceuticals Corporation | BETOPTIC S | betaxolol hydrochloride | 0078-0729 | MANNITOL | |
| Novartis Pharmaceuticals Corporation | BETOPTIC S | betaxolol hydrochloride | 0078-0729 | SODIUM HYDROXIDE | |
| Novartis Pharmaceuticals Corporation | BETOPTIC S | betaxolol hydrochloride | 0078-0729 | WATER | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing betaxolol hydrochloride
Detailed excipient profiles for betaxolol hydrochloride
Excipient focus: ANHYDROUS LACTOSE
betaxolol hydrochloride drug variants containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| KVK-TECH INC | betaxolol hydrochloride | 10702-013 |
| >Company | >Ingredient | >NDC |
betaxolol hydrochloride drug variants not containing ANHYDROUS LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | betaxolol hydrochloride | 0078-0729 |
| Akorn | betaxolol hydrochloride | 17478-705 |
| Sandoz Inc | betaxolol hydrochloride | 61314-245 |
| >Company | >Ingredient | >NDC |
Excipient focus: BENZALKONIUM CHLORIDE
betaxolol hydrochloride drug variants containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | betaxolol hydrochloride | 0078-0729 |
| Akorn | betaxolol hydrochloride | 17478-705 |
| Sandoz Inc | betaxolol hydrochloride | 61314-245 |
| >Company | >Ingredient | >NDC |
betaxolol hydrochloride drug variants not containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| KVK-TECH INC | betaxolol hydrochloride | 10702-013 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
betaxolol hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| KVK-TECH INC | betaxolol hydrochloride | 10702-013 |
| >Company | >Ingredient | >NDC |
betaxolol hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | betaxolol hydrochloride | 0078-0729 |
| Akorn | betaxolol hydrochloride | 17478-705 |
| Sandoz Inc | betaxolol hydrochloride | 61314-245 |
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
betaxolol hydrochloride drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | betaxolol hydrochloride | 0078-0729 |
| Akorn | betaxolol hydrochloride | 17478-705 |
| Sandoz Inc | betaxolol hydrochloride | 61314-245 |
| >Company | >Ingredient | >NDC |
betaxolol hydrochloride drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| KVK-TECH INC | betaxolol hydrochloride | 10702-013 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
betaxolol hydrochloride drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | betaxolol hydrochloride | 0078-0729 |
| Akorn | betaxolol hydrochloride | 17478-705 |
| Sandoz Inc | betaxolol hydrochloride | 61314-245 |
| >Company | >Ingredient | >NDC |
betaxolol hydrochloride drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| KVK-TECH INC | betaxolol hydrochloride | 10702-013 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
betaxolol hydrochloride drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| KVK-TECH INC | betaxolol hydrochloride | 10702-013 |
| >Company | >Ingredient | >NDC |
betaxolol hydrochloride drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | betaxolol hydrochloride | 0078-0729 |
| Akorn | betaxolol hydrochloride | 17478-705 |
| Sandoz Inc | betaxolol hydrochloride | 61314-245 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
betaxolol hydrochloride drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | betaxolol hydrochloride | 0078-0729 |
| >Company | >Ingredient | >NDC |
betaxolol hydrochloride drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| KVK-TECH INC | betaxolol hydrochloride | 10702-013 |
| Akorn | betaxolol hydrochloride | 17478-705 |
| Sandoz Inc | betaxolol hydrochloride | 61314-245 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
betaxolol hydrochloride drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| KVK-TECH INC | betaxolol hydrochloride | 10702-013 |
| >Company | >Ingredient | >NDC |
betaxolol hydrochloride drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | betaxolol hydrochloride | 0078-0729 |
| Akorn | betaxolol hydrochloride | 17478-705 |
| Sandoz Inc | betaxolol hydrochloride | 61314-245 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
betaxolol hydrochloride drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| KVK-TECH INC | betaxolol hydrochloride | 10702-013 |
| >Company | >Ingredient | >NDC |
betaxolol hydrochloride drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | betaxolol hydrochloride | 0078-0729 |
| Akorn | betaxolol hydrochloride | 17478-705 |
| Sandoz Inc | betaxolol hydrochloride | 61314-245 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
betaxolol hydrochloride drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | betaxolol hydrochloride | 17478-705 |
| Sandoz Inc | betaxolol hydrochloride | 61314-245 |
| >Company | >Ingredient | >NDC |
betaxolol hydrochloride drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | betaxolol hydrochloride | 0078-0729 |
| KVK-TECH INC | betaxolol hydrochloride | 10702-013 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
betaxolol hydrochloride drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | betaxolol hydrochloride | 0078-0729 |
| Akorn | betaxolol hydrochloride | 17478-705 |
| Sandoz Inc | betaxolol hydrochloride | 61314-245 |
| >Company | >Ingredient | >NDC |
betaxolol hydrochloride drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| KVK-TECH INC | betaxolol hydrochloride | 10702-013 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
betaxolol hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| KVK-TECH INC | betaxolol hydrochloride | 10702-013 |
| >Company | >Ingredient | >NDC |
betaxolol hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | betaxolol hydrochloride | 0078-0729 |
| Akorn | betaxolol hydrochloride | 17478-705 |
| Sandoz Inc | betaxolol hydrochloride | 61314-245 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
betaxolol hydrochloride drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| KVK-TECH INC | betaxolol hydrochloride | 10702-013 |
| >Company | >Ingredient | >NDC |
betaxolol hydrochloride drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | betaxolol hydrochloride | 0078-0729 |
| Akorn | betaxolol hydrochloride | 17478-705 |
| Sandoz Inc | betaxolol hydrochloride | 61314-245 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
betaxolol hydrochloride drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| KVK-TECH INC | betaxolol hydrochloride | 10702-013 |
| >Company | >Ingredient | >NDC |
betaxolol hydrochloride drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | betaxolol hydrochloride | 0078-0729 |
| Akorn | betaxolol hydrochloride | 17478-705 |
| Sandoz Inc | betaxolol hydrochloride | 61314-245 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
betaxolol hydrochloride drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| KVK-TECH INC | betaxolol hydrochloride | 10702-013 |
| >Company | >Ingredient | >NDC |
betaxolol hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | betaxolol hydrochloride | 0078-0729 |
| Akorn | betaxolol hydrochloride | 17478-705 |
| Sandoz Inc | betaxolol hydrochloride | 61314-245 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
betaxolol hydrochloride drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | betaxolol hydrochloride | 0078-0729 |
| Sandoz Inc | betaxolol hydrochloride | 61314-245 |
| >Company | >Ingredient | >NDC |
betaxolol hydrochloride drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| KVK-TECH INC | betaxolol hydrochloride | 10702-013 |
| Akorn | betaxolol hydrochloride | 17478-705 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
